Industry Research Reports

Home > Reports > Medical Devices & Consumables > Medical Transdermal Patch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Medical Transdermal Patch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-01-13

Pages: 144 Pages

Report ld: 3498077

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Medical Transdermal Patch was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Medical Transdermal Patch, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Medical Transdermal Patch by region & country, by Type, and by Application.

The Medical Transdermal Patch market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Transdermal Patch.

MARKET SEGMENTATION

By Company

Hisamitsu Pharmaceutical
Johnson & Johnson
Novartis
UCB Pharma
Mylan
Teva Pharmaceutical
Nitto Denko
Grunenthal
IBSA Group
GSK
Luye Pharma Group
Pfizer
Chattem
Bayer
Mundipharma
Endo International
Beijing Tide Pharmaceutical

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Methyl Salicylate-based Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others

Segment by Application

Rx Channel
OTC Channel

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Medical Transdermal Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Medical Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Medical Transdermal Patch in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Medical Transdermal Patch Product Introduction

1.2 Global Medical Transdermal Patch Market Size Forecast

1.2.1 Global Medical Transdermal Patch Sales Value (2020-2031)

1.2.2 Global Medical Transdermal Patch Sales Volume (2020-2031)

1.2.3 Global Medical Transdermal Patch Sales Price (2020-2031)

1.3 Medical Transdermal Patch Market Trends & Drivers

1.3.1 Medical Transdermal Patch Industry Trends

1.3.2 Medical Transdermal Patch Market Drivers & Opportunity

1.3.3 Medical Transdermal Patch Market Challenges

1.3.4 Medical Transdermal Patch Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Medical Transdermal Patch Players Revenue Ranking (2024)

2.2 Global Medical Transdermal Patch Revenue by Company (2020-2025)

2.3 Global Medical Transdermal Patch Players Sales Volume Ranking (2024)

2.4 Global Medical Transdermal Patch Sales Volume by Company Players (2020-2025)

2.5 Global Medical Transdermal Patch Average Price by Company (2020-2025)

2.6 Key Manufacturers Medical Transdermal Patch Manufacturing Base and Headquarters

2.7 Key Manufacturers Medical Transdermal Patch Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Medical Transdermal Patch

2.9 Medical Transdermal Patch Market Competitive Analysis

2.9.1 Medical Transdermal Patch Market Concentration Rate (2020-2025)

2.9.2 Global 5 and 10 Largest Manufacturers by Medical Transdermal Patch Revenue in 2024

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Transdermal Patch as of 2024)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Methyl Salicylate-based Patch

3.1.2 Diclofenac Patch

3.1.3 Nicotine Transdermal Patch

3.1.4 Others

3.2 Global Medical Transdermal Patch Sales Value by Type

3.2.1 Global Medical Transdermal Patch Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Medical Transdermal Patch Sales Value, by Type (2020-2031)

3.2.3 Global Medical Transdermal Patch Sales Value, by Type (%) (2020-2031)

3.3 Global Medical Transdermal Patch Sales Volume by Type

3.3.1 Global Medical Transdermal Patch Sales Volume by Type (2020 VS 2024 VS 2031)

3.3.2 Global Medical Transdermal Patch Sales Volume, by Type (2020-2031)

3.3.3 Global Medical Transdermal Patch Sales Volume, by Type (%) (2020-2031)

3.4 Global Medical Transdermal Patch Average Price by Type (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Rx Channel

4.1.2 OTC Channel

4.2 Global Medical Transdermal Patch Sales Value by Application

4.2.1 Global Medical Transdermal Patch Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Medical Transdermal Patch Sales Value, by Application (2020-2031)

4.2.3 Global Medical Transdermal Patch Sales Value, by Application (%) (2020-2031)

4.3 Global Medical Transdermal Patch Sales Volume by Application

4.3.1 Global Medical Transdermal Patch Sales Volume by Application (2020 VS 2024 VS 2031)

4.3.2 Global Medical Transdermal Patch Sales Volume, by Application (2020-2031)

4.3.3 Global Medical Transdermal Patch Sales Volume, by Application (%) (2020-2031)

4.4 Global Medical Transdermal Patch Average Price by Application (2020-2031)

5 Segmentation by Region

5.1 Global Medical Transdermal Patch Sales Value by Region

5.1.1 Global Medical Transdermal Patch Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Medical Transdermal Patch Sales Value by Region (2020-2025)

5.1.3 Global Medical Transdermal Patch Sales Value by Region (2026-2031)

5.1.4 Global Medical Transdermal Patch Sales Value by Region (%), (2020-2031)

5.2 Global Medical Transdermal Patch Sales Volume by Region

5.2.1 Global Medical Transdermal Patch Sales Volume by Region: 2020 VS 2024 VS 2031

5.2.2 Global Medical Transdermal Patch Sales Volume by Region (2020-2025)

5.2.3 Global Medical Transdermal Patch Sales Volume by Region (2026-2031)

5.2.4 Global Medical Transdermal Patch Sales Volume by Region (%), (2020-2031)

5.3 Global Medical Transdermal Patch Average Price by Region (2020-2031)

5.4 North America

5.4.1 North America Medical Transdermal Patch Sales Value, 2020-2031

5.4.2 North America Medical Transdermal Patch Sales Value by Country (%), 2024 VS 2031

5.5 Europe

5.5.1 Europe Medical Transdermal Patch Sales Value, 2020-2031

5.5.2 Europe Medical Transdermal Patch Sales Value by Country (%), 2024 VS 2031

5.6 Asia Pacific

5.6.1 Asia Pacific Medical Transdermal Patch Sales Value, 2020-2031

5.6.2 Asia Pacific Medical Transdermal Patch Sales Value by Region (%), 2024 VS 2031

5.7 South America

5.7.1 South America Medical Transdermal Patch Sales Value, 2020-2031

5.7.2 South America Medical Transdermal Patch Sales Value by Country (%), 2024 VS 2031

5.8 Middle East & Africa

5.8.1 Middle East & Africa Medical Transdermal Patch Sales Value, 2020-2031

5.8.2 Middle East & Africa Medical Transdermal Patch Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Medical Transdermal Patch Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Medical Transdermal Patch Sales Value

6.2.1 Key Countries/Regions Medical Transdermal Patch Sales Value, 2020-2031

6.2.2 Key Countries/Regions Medical Transdermal Patch Sales Volume, 2020-2031

6.3 United States

6.3.1 United States Medical Transdermal Patch Sales Value, 2020-2031

6.3.2 United States Medical Transdermal Patch Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Medical Transdermal Patch Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Medical Transdermal Patch Sales Value, 2020-2031

6.4.2 Europe Medical Transdermal Patch Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Medical Transdermal Patch Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Medical Transdermal Patch Sales Value, 2020-2031

6.5.2 China Medical Transdermal Patch Sales Value by Type (%), 2024 VS 2031

6.5.3 China Medical Transdermal Patch Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Medical Transdermal Patch Sales Value, 2020-2031

6.6.2 Japan Medical Transdermal Patch Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Medical Transdermal Patch Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Medical Transdermal Patch Sales Value, 2020-2031

6.7.2 South Korea Medical Transdermal Patch Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Medical Transdermal Patch Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Medical Transdermal Patch Sales Value, 2020-2031

6.8.2 Southeast Asia Medical Transdermal Patch Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Medical Transdermal Patch Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Medical Transdermal Patch Sales Value, 2020-2031

6.9.2 India Medical Transdermal Patch Sales Value by Type (%), 2024 VS 2031

6.9.3 India Medical Transdermal Patch Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Hisamitsu Pharmaceutical

7.1.1 Hisamitsu Pharmaceutical Company Information

7.1.2 Hisamitsu Pharmaceutical Introduction and Business Overview

7.1.3 Hisamitsu Pharmaceutical Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.1.4 Hisamitsu Pharmaceutical Medical Transdermal Patch Product Offerings

7.1.5 Hisamitsu Pharmaceutical Recent Development

7.2 Johnson & Johnson

7.2.1 Johnson & Johnson Company Information

7.2.2 Johnson & Johnson Introduction and Business Overview

7.2.3 Johnson & Johnson Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.2.4 Johnson & Johnson Medical Transdermal Patch Product Offerings

7.2.5 Johnson & Johnson Recent Development

7.3 Novartis

7.3.1 Novartis Company Information

7.3.2 Novartis Introduction and Business Overview

7.3.3 Novartis Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.3.4 Novartis Medical Transdermal Patch Product Offerings

7.3.5 Novartis Recent Development

7.4 UCB Pharma

7.4.1 UCB Pharma Company Information

7.4.2 UCB Pharma Introduction and Business Overview

7.4.3 UCB Pharma Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.4.4 UCB Pharma Medical Transdermal Patch Product Offerings

7.4.5 UCB Pharma Recent Development

7.5 Mylan

7.5.1 Mylan Company Information

7.5.2 Mylan Introduction and Business Overview

7.5.3 Mylan Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.5.4 Mylan Medical Transdermal Patch Product Offerings

7.5.5 Mylan Recent Development

7.6 Teva Pharmaceutical

7.6.1 Teva Pharmaceutical Company Information

7.6.2 Teva Pharmaceutical Introduction and Business Overview

7.6.3 Teva Pharmaceutical Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.6.4 Teva Pharmaceutical Medical Transdermal Patch Product Offerings

7.6.5 Teva Pharmaceutical Recent Development

7.7 Nitto Denko

7.7.1 Nitto Denko Company Information

7.7.2 Nitto Denko Introduction and Business Overview

7.7.3 Nitto Denko Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.7.4 Nitto Denko Medical Transdermal Patch Product Offerings

7.7.5 Nitto Denko Recent Development

7.8 Grunenthal

7.8.1 Grunenthal Company Information

7.8.2 Grunenthal Introduction and Business Overview

7.8.3 Grunenthal Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.8.4 Grunenthal Medical Transdermal Patch Product Offerings

7.8.5 Grunenthal Recent Development

7.9 IBSA Group

7.9.1 IBSA Group Company Information

7.9.2 IBSA Group Introduction and Business Overview

7.9.3 IBSA Group Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.9.4 IBSA Group Medical Transdermal Patch Product Offerings

7.9.5 IBSA Group Recent Development

7.10 GSK

7.10.1 GSK Company Information

7.10.2 GSK Introduction and Business Overview

7.10.3 GSK Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.10.4 GSK Medical Transdermal Patch Product Offerings

7.10.5 GSK Recent Development

7.11 Luye Pharma Group

7.11.1 Luye Pharma Group Company Information

7.11.2 Luye Pharma Group Introduction and Business Overview

7.11.3 Luye Pharma Group Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.11.4 Luye Pharma Group Medical Transdermal Patch Product Offerings

7.11.5 Luye Pharma Group Recent Development

7.12 Pfizer

7.12.1 Pfizer Company Information

7.12.2 Pfizer Introduction and Business Overview

7.12.3 Pfizer Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.12.4 Pfizer Medical Transdermal Patch Product Offerings

7.12.5 Pfizer Recent Development

7.13 Chattem

7.13.1 Chattem Company Information

7.13.2 Chattem Introduction and Business Overview

7.13.3 Chattem Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.13.4 Chattem Medical Transdermal Patch Product Offerings

7.13.5 Chattem Recent Development

7.14 Bayer

7.14.1 Bayer Company Information

7.14.2 Bayer Introduction and Business Overview

7.14.3 Bayer Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.14.4 Bayer Medical Transdermal Patch Product Offerings

7.14.5 Bayer Recent Development

7.15 Mundipharma

7.15.1 Mundipharma Company Information

7.15.2 Mundipharma Introduction and Business Overview

7.15.3 Mundipharma Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.15.4 Mundipharma Medical Transdermal Patch Product Offerings

7.15.5 Mundipharma Recent Development

7.16 Endo International

7.16.1 Endo International Company Information

7.16.2 Endo International Introduction and Business Overview

7.16.3 Endo International Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.16.4 Endo International Medical Transdermal Patch Product Offerings

7.16.5 Endo International Recent Development

7.17 Beijing Tide Pharmaceutical

7.17.1 Beijing Tide Pharmaceutical Company Information

7.17.2 Beijing Tide Pharmaceutical Introduction and Business Overview

7.17.3 Beijing Tide Pharmaceutical Medical Transdermal Patch Sales, Revenue, Price and Gross Margin (2020-2025)

7.17.4 Beijing Tide Pharmaceutical Medical Transdermal Patch Product Offerings

7.17.5 Beijing Tide Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Medical Transdermal Patch Industrial Chain

8.2 Medical Transdermal Patch Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Medical Transdermal Patch Sales Model

8.5.2 Sales Channel

8.5.3 Medical Transdermal Patch Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Medical Transdermal Patch Market Trends

Table 2. Medical Transdermal Patch Market Drivers & Opportunity

Table 3. Medical Transdermal Patch Market Challenges

Table 4. Medical Transdermal Patch Market Restraints

Table 5. Global Medical Transdermal Patch Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Medical Transdermal Patch Revenue Market Share by Company (2020-2025)

Table 7. Global Medical Transdermal Patch Sales Volume by Company (2020-2025) & (K Units)

Table 8. Global Medical Transdermal Patch Sales Volume Market Share by Company (2020-2025)

Table 9. Global Market Medical Transdermal Patch Price by Company (2020-2025) & (US$/Unit)

Table 10. Key Manufacturers Medical Transdermal Patch Manufacturing Base and Headquarters

Table 11. Key Manufacturers Medical Transdermal Patch Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Medical Transdermal Patch

Table 13. Global Medical Transdermal Patch Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Transdermal Patch as of 2024)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Medical Transdermal Patch Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 17. Global Medical Transdermal Patch Sales Value by Type (2020-2025) & (US$ Million)

Table 18. Global Medical Transdermal Patch Sales Value by Type (2026-2031) & (US$ Million)

Table 19. Global Medical Transdermal Patch Sales Market Share in Value by Type (2020-2025)

Table 20. Global Medical Transdermal Patch Sales Market Share in Value by Type (2026-2031)

Table 21. Global Medical Transdermal Patch Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)

Table 22. Global Medical Transdermal Patch Sales Volume by Type (2020-2025) & (K Units)

Table 23. Global Medical Transdermal Patch Sales Volume by Type (2026-2031) & (K Units)

Table 24. Global Medical Transdermal Patch Sales Market Share in Volume by Type (2020-2025)

Table 25. Global Medical Transdermal Patch Sales Market Share in Volume by Type (2026-2031)

Table 26. Global Medical Transdermal Patch Price by Type (2020-2025) & (US$/Unit)

Table 27. Global Medical Transdermal Patch Price by Type (2026-2031) & (US$/Unit)

Table 28. Global Medical Transdermal Patch Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 29. Global Medical Transdermal Patch Sales Value by Application (2020-2025) & (US$ Million)

Table 30. Global Medical Transdermal Patch Sales Value by Application (2026-2031) & (US$ Million)

Table 31. Global Medical Transdermal Patch Sales Market Share in Value by Application (2020-2025)

Table 32. Global Medical Transdermal Patch Sales Market Share in Value by Application (2026-2031)

Table 33. Global Medical Transdermal Patch Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)

Table 34. Global Medical Transdermal Patch Sales Volume by Application (2020-2025) & (K Units)

Table 35. Global Medical Transdermal Patch Sales Volume by Application (2026-2031) & (K Units)

Table 36. Global Medical Transdermal Patch Sales Market Share in Volume by Application (2020-2025)

Table 37. Global Medical Transdermal Patch Sales Market Share in Volume by Application (2026-2031)

Table 38. Global Medical Transdermal Patch Price by Application (2020-2025) & (US$/Unit)

Table 39. Global Medical Transdermal Patch Price by Application (2026-2031) & (US$/Unit)

Table 40. Global Medical Transdermal Patch Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 41. Global Medical Transdermal Patch Sales Value by Region (2020-2025) & (US$ Million)

Table 42. Global Medical Transdermal Patch Sales Value by Region (2026-2031) & (US$ Million)

Table 43. Global Medical Transdermal Patch Sales Value by Region (2020-2025) & (%)

Table 44. Global Medical Transdermal Patch Sales Value by Region (2026-2031) & (%)

Table 45. Global Medical Transdermal Patch Sales Volume by Region (K Units): 2020 VS 2024 VS 2031

Table 46. Global Medical Transdermal Patch Sales Volume by Region (2020-2025) & (K Units)

Table 47. Global Medical Transdermal Patch Sales Volume by Region (2026-2031) & (K Units)

Table 48. Global Medical Transdermal Patch Sales Volume by Region (2020-2025) & (%)

Table 49. Global Medical Transdermal Patch Sales Volume by Region (2026-2031) & (%)

Table 50. Global Medical Transdermal Patch Average Price by Region (2020-2025) & (US$/Unit)

Table 51. Global Medical Transdermal Patch Average Price by Region (2026-2031) & (US$/Unit)

Table 52. Key Countries/Regions Medical Transdermal Patch Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 53. Key Countries/Regions Medical Transdermal Patch Sales Value, (2020-2025) & (US$ Million)

Table 54. Key Countries/Regions Medical Transdermal Patch Sales Value, (2026-2031) & (US$ Million)

Table 55. Key Countries/Regions Medical Transdermal Patch Sales Volume, (2020-2025) & (K Units)

Table 56. Key Countries/Regions Medical Transdermal Patch Sales Volume, (2026-2031) & (K Units)

Table 57. Hisamitsu Pharmaceutical Company Information

Table 58. Hisamitsu Pharmaceutical Introduction and Business Overview

Table 59. Hisamitsu Pharmaceutical Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 60. Hisamitsu Pharmaceutical Medical Transdermal Patch Product Offerings

Table 61. Hisamitsu Pharmaceutical Recent Development

Table 62. Johnson & Johnson Company Information

Table 63. Johnson & Johnson Introduction and Business Overview

Table 64. Johnson & Johnson Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 65. Johnson & Johnson Medical Transdermal Patch Product Offerings

Table 66. Johnson & Johnson Recent Development

Table 67. Novartis Company Information

Table 68. Novartis Introduction and Business Overview

Table 69. Novartis Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 70. Novartis Medical Transdermal Patch Product Offerings

Table 71. Novartis Recent Development

Table 72. UCB Pharma Company Information

Table 73. UCB Pharma Introduction and Business Overview

Table 74. UCB Pharma Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. UCB Pharma Medical Transdermal Patch Product Offerings

Table 76. UCB Pharma Recent Development

Table 77. Mylan Company Information

Table 78. Mylan Introduction and Business Overview

Table 79. Mylan Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. Mylan Medical Transdermal Patch Product Offerings

Table 81. Mylan Recent Development

Table 82. Teva Pharmaceutical Company Information

Table 83. Teva Pharmaceutical Introduction and Business Overview

Table 84. Teva Pharmaceutical Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. Teva Pharmaceutical Medical Transdermal Patch Product Offerings

Table 86. Teva Pharmaceutical Recent Development

Table 87. Nitto Denko Company Information

Table 88. Nitto Denko Introduction and Business Overview

Table 89. Nitto Denko Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Nitto Denko Medical Transdermal Patch Product Offerings

Table 91. Nitto Denko Recent Development

Table 92. Grunenthal Company Information

Table 93. Grunenthal Introduction and Business Overview

Table 94. Grunenthal Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 95. Grunenthal Medical Transdermal Patch Product Offerings

Table 96. Grunenthal Recent Development

Table 97. IBSA Group Company Information

Table 98. IBSA Group Introduction and Business Overview

Table 99. IBSA Group Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 100. IBSA Group Medical Transdermal Patch Product Offerings

Table 101. IBSA Group Recent Development

Table 102. GSK Company Information

Table 103. GSK Introduction and Business Overview

Table 104. GSK Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 105. GSK Medical Transdermal Patch Product Offerings

Table 106. GSK Recent Development

Table 107. Luye Pharma Group Company Information

Table 108. Luye Pharma Group Introduction and Business Overview

Table 109. Luye Pharma Group Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 110. Luye Pharma Group Medical Transdermal Patch Product Offerings

Table 111. Luye Pharma Group Recent Development

Table 112. Pfizer Company Information

Table 113. Pfizer Introduction and Business Overview

Table 114. Pfizer Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 115. Pfizer Medical Transdermal Patch Product Offerings

Table 116. Pfizer Recent Development

Table 117. Chattem Company Information

Table 118. Chattem Introduction and Business Overview

Table 119. Chattem Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 120. Chattem Medical Transdermal Patch Product Offerings

Table 121. Chattem Recent Development

Table 122. Bayer Company Information

Table 123. Bayer Introduction and Business Overview

Table 124. Bayer Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 125. Bayer Medical Transdermal Patch Product Offerings

Table 126. Bayer Recent Development

Table 127. Mundipharma Company Information

Table 128. Mundipharma Introduction and Business Overview

Table 129. Mundipharma Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 130. Mundipharma Medical Transdermal Patch Product Offerings

Table 131. Mundipharma Recent Development

Table 132. Endo International Company Information

Table 133. Endo International Introduction and Business Overview

Table 134. Endo International Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 135. Endo International Medical Transdermal Patch Product Offerings

Table 136. Endo International Recent Development

Table 137. Beijing Tide Pharmaceutical Company Information

Table 138. Beijing Tide Pharmaceutical Introduction and Business Overview

Table 139. Beijing Tide Pharmaceutical Medical Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 140. Beijing Tide Pharmaceutical Medical Transdermal Patch Product Offerings

Table 141. Beijing Tide Pharmaceutical Recent Development

Table 142. Key Raw Materials Lists

Table 143. Raw Materials Key Suppliers Lists

Table 144. Medical Transdermal Patch Downstream Customers

Table 145. Medical Transdermal Patch Distributors List

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

List of Figures

Figure 1. Medical Transdermal Patch Product Picture

Figure 2. Global Medical Transdermal Patch Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Medical Transdermal Patch Sales Value (2020-2031) & (US$ Million)

Figure 4. Global Medical Transdermal Patch Sales Volume (2020-2031) & (K Units)

Figure 5. Global Medical Transdermal Patch Sales Price (2020-2031) & (US$/Unit)

Figure 6. Medical Transdermal Patch Report Years Considered

Figure 7. Global Medical Transdermal Patch Players Revenue Ranking (2024) & (US$ Million)

Figure 8. Global Medical Transdermal Patch Players Sales Volume Ranking (2024) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Medical Transdermal Patch Revenue in 2024

Figure 10. Medical Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 11. Methyl Salicylate-based Patch Picture

Figure 12. Diclofenac Patch Picture

Figure 13. Nicotine Transdermal Patch Picture

Figure 14. Others Picture

Figure 15. Global Medical Transdermal Patch Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 16. Global Medical Transdermal Patch Sales Value Market Share by Type, 2024 & 2031

Figure 17. Global Medical Transdermal Patch Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)

Figure 18. Global Medical Transdermal Patch Sales Volume Market Share by Type, 2024 & 2031

Figure 19. Global Medical Transdermal Patch Price by Type (2020-2031) & (US$/Unit)

Figure 20. Product Picture of Rx Channel

Figure 21. Product Picture of OTC Channel

Figure 22. Global Medical Transdermal Patch Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 23. Global Medical Transdermal Patch Sales Value Market Share by Application, 2024 & 2031

Figure 24. Global Medical Transdermal Patch Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)

Figure 25. Global Medical Transdermal Patch Sales Volume Market Share by Application, 2024 & 2031

Figure 26. Global Medical Transdermal Patch Price by Application (2020-2031) & (US$/Unit)

Figure 27. North America Medical Transdermal Patch Sales Value (2020-2031) & (US$ Million)

Figure 28. North America Medical Transdermal Patch Sales Value by Country (%), 2024 VS 2031

Figure 29. Europe Medical Transdermal Patch Sales Value, (2020-2031) & (US$ Million)

Figure 30. Europe Medical Transdermal Patch Sales Value by Country (%), 2024 VS 2031

Figure 31. Asia Pacific Medical Transdermal Patch Sales Value, (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Medical Transdermal Patch Sales Value by Region (%), 2024 VS 2031

Figure 33. South America Medical Transdermal Patch Sales Value, (2020-2031) & (US$ Million)

Figure 34. South America Medical Transdermal Patch Sales Value by Country (%), 2024 VS 2031

Figure 35. Middle East & Africa Medical Transdermal Patch Sales Value, (2020-2031) & (US$ Million)

Figure 36. Middle East & Africa Medical Transdermal Patch Sales Value by Country (%), 2024 VS 2031

Figure 37. Key Countries/Regions Medical Transdermal Patch Sales Value (%), (2020-2031)

Figure 38. Key Countries/Regions Medical Transdermal Patch Sales Volume (%), (2020-2031)

Figure 39. United States Medical Transdermal Patch Sales Value, (2020-2031) & (US$ Million)

Figure 40. United States Medical Transdermal Patch Sales Value by Type (%), 2024 VS 2031

Figure 41. United States Medical Transdermal Patch Sales Value by Application (%), 2024 VS 2031

Figure 42. Europe Medical Transdermal Patch Sales Value, (2020-2031) & (US$ Million)

Figure 43. Europe Medical Transdermal Patch Sales Value by Type (%), 2024 VS 2031

Figure 44. Europe Medical Transdermal Patch Sales Value by Application (%), 2024 VS 2031

Figure 45. China Medical Transdermal Patch Sales Value, (2020-2031) & (US$ Million)

Figure 46. China Medical Transdermal Patch Sales Value by Type (%), 2024 VS 2031

Figure 47. China Medical Transdermal Patch Sales Value by Application (%), 2024 VS 2031

Figure 48. Japan Medical Transdermal Patch Sales Value, (2020-2031) & (US$ Million)

Figure 49. Japan Medical Transdermal Patch Sales Value by Type (%), 2024 VS 2031

Figure 50. Japan Medical Transdermal Patch Sales Value by Application (%), 2024 VS 2031

Figure 51. South Korea Medical Transdermal Patch Sales Value, (2020-2031) & (US$ Million)

Figure 52. South Korea Medical Transdermal Patch Sales Value by Type (%), 2024 VS 2031

Figure 53. South Korea Medical Transdermal Patch Sales Value by Application (%), 2024 VS 2031

Figure 54. Southeast Asia Medical Transdermal Patch Sales Value, (2020-2031) & (US$ Million)

Figure 55. Southeast Asia Medical Transdermal Patch Sales Value by Type (%), 2024 VS 2031

Figure 56. Southeast Asia Medical Transdermal Patch Sales Value by Application (%), 2024 VS 2031

Figure 57. India Medical Transdermal Patch Sales Value, (2020-2031) & (US$ Million)

Figure 58. India Medical Transdermal Patch Sales Value by Type (%), 2024 VS 2031

Figure 59. India Medical Transdermal Patch Sales Value by Application (%), 2024 VS 2031

Figure 60. Medical Transdermal Patch Industrial Chain

Figure 61. Medical Transdermal Patch Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Medical Transdermal Patch market? zhanKai

The top companies in the global Medical Transdermal Patch market are Hisamitsu Pharmaceutical、Johnson & Johnson、Novartis.

Related Reports

Medical Transdermal Patch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Medical Transdermal Patch was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 151
USD 3950.00
(Single User License)
Global Medical Transdermal Patch Market Research Report 2026
The global Medical Transdermal Patch market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 130
USD 2900.00
(Single User License)
Global Medical Transdermal Patch Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Medical Transdermal Patch market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 105
USD 4250.00
(Single User License)
Global Medical Transdermal Patch Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Medical Transdermal Patch market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 173
USD 4900.00
(Single User License)
Global Medical Transdermal Patch Market Research Report 2025
The global market for Medical Transdermal Patch was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 102
USD 2900.00
(Single User License)
Global Medical Transdermal Patch Market Research Report 2024
A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. An advantage of a transdermal drug delivery route over other types of medication delivery (such as oral, topical, intravenous, or intramuscular) is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The main disadvantage to transdermal delivery systems stems from the fact that the skin is a very effective barrier; as a result, only medications whose molecules are small enough to penetrate the skin can be delivered by this method.
Published Date: 2024-02-07
Pages: 105
USD 2900.00
(Single User License)

Medical Transdermal Patch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Medical Transdermal Patch was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 151
USD 3950.00 (Single User License)
Global Medical Transdermal Patch Market Research Report 2026
The global Medical Transdermal Patch market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 130
USD 2900.00 (Single User License)
Global Medical Transdermal Patch Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Medical Transdermal Patch market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 105
USD 4250.00 (Single User License)
Global Medical Transdermal Patch Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Medical Transdermal Patch market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 173
USD 4900.00 (Single User License)
Global Medical Transdermal Patch Market Research Report 2025
The global market for Medical Transdermal Patch was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 102
USD 2900.00 (Single User License)
Global Medical Transdermal Patch Market Research Report 2024
A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. An advantage of a transdermal drug delivery route over other types of medication delivery (such as oral, topical, intravenous, or intramuscular) is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive. The main disadvantage to transdermal delivery systems stems from the fact that the skin is a very effective barrier; as a result, only medications whose molecules are small enough to penetrate the skin can be delivered by this method.
Published: 2024-02-07
Pages: 105
USD 2900.00 (Single User License)